Clinical Trial Update: Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

View source ↗

Summary

A University of Maryland-led trial protocol aims to develop and validate an epigenetic assay to diagnose breast cancer. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Breast Cancer (Locally Advanced or Metastatic), Healthy Volunteers (HV) | Status: NOT_YET_RECRUITING